Characteristics of included study
Methods	X‐armed, double/single/non‐blinded, parallel‐group/cross‐over/cluster randomised controlled trial, with x duration of treatment and x duration of follow‐up
Participants	Location: place, country Setting: single‐/multicentre, department, hospital, study duration Sample size: Number randomised: x in test group, y in control group Number completed: x in test group, y in control group Participant baseline characteristics: Age: Gender: Duration of tinnitus: Tinnitus severity: Tinnitus loudness: Tinnitus quality: Hearing loss: degree, characteristics, pure‐tone audiograms Anxiety/depression score: Inclusion criteria: Exclusion criteria:
Interventions	Intervention group: drug name, method of administration, dosage per day, frequency of administration, duration of intervention Comparator group: drug name, method of administration, dosage per day, frequency of administration, duration of intervention Use of additional interventions:
Outcomes	Outcome measure(s): Time point(s): Outcome type: continuous/dichotomous/adverse effects Reported as: mean with confidence intervals/standard deviation/standard error Range: Unit of measurement: Direction: lower is better/higher is better Statistical tests used: Treatment fidelity:
Funding sources	No information provided/none declared/state source of funding
Declarations of interest	No information provided/none declared/state conflict(s)
Notes